Earnings Feed
Start Free
CANCERVAX CORP·4

Nov 6, 5:57 PM ET

PETRICCIANI JOHN 4

4 · CANCERVAX CORP · Filed Nov 6, 2003

Insider Transaction Report

Form 4
Period: 2003-11-04
CANCERVAX CORPCNVX
PETRICCIANI JOHN
Sr.VP, Medical & Regulatory
Transactions
  • Conversion

    Common Stock

    2003-11-04+19,763→ 53,853 total
  • Conversion

    Common Stock

    2003-11-04+9,825→ 63,678 total
  • Conversion

    Series A Preferred Stock

    2003-11-04−19,763→ 0 total
    Exercise: $10.12→ Common Stock (19,763 underlying)
  • Conversion

    Series C Preferred Stock

    2003-11-04−11,307→ 0 total
    Exercise: $8.84→ Common Stock (11,307 underlying)
  • Conversion

    Common Stock

    2003-11-04+11,307→ 74,985 total
  • Conversion

    Series B Preferred Stock

    2003-11-04−9,825→ 0 total
    Exercise: $9.68→ Common Stock (9,825 underlying)
Footnotes (2)
  • [F1]Not applicable to this transaction.
  • [F2]Immediately convertible.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION